Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Alefacept does not effectively treat severe alopecia areata.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.